Sartorius Stedim Biotech Stock
Stocks
DIM
FR0013154002
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Euronext Paris
11:55:00 2026-08-31 EDT
|
5-day change | 1st Jan Change | ||
| 196.00 EUR | -0.86% |
|
+1.29% | -6.67% |
| 08-20 | UBS Upgrades Sartorius Stedim Biotech to Buy, Boosts PT | MT |
| 08-20 | European stock markets slip as oil prices surge again |  |
| Market Cap | 19.07B 22.15B 17.9B 16.35B 30.69B 2,109B 30.9B 212B 82.54B 1,069B 83.17B 81.35B 3,539B | P/E 2026 * |
50.2x | P/E 2027 * | 39x |
|---|---|---|---|---|---|
| Enterprise Value | 21.08B 24.49B 19.78B 18.07B 33.92B 2,331B 34.16B 234B 91.24B 1,182B 91.93B 89.92B 3,912B | EV / Sales 2026 * |
6.74x | EV / Sales 2027 * | 6.01x |
| Free-Float |
28.47% | Yield 2026 * |
0.42% | Yield 2027 * | 0.51% |
Last Transcript : Sartorius Stedim Biotech
| 1 day | -0.86% | ||
| 1 week | +1.29% | ||
| Current month | +17.58% | ||
| 1 month | +15.23% | ||
| 3 months | +10.05% | ||
| 6 months | +9.07% | ||
| Current year | -6.67% |
| 1 week | 190.4 |  | 199.5 |
| 1 month | 166 | | 199.5 |
| Current year | 150 | | 224 |
| 1 year | 150 | | 224 |
| 3 years | 139.1 | | 281 |
| 5 years | 139.1 | | 551 |
| 10 years | 50.13 | | 551 |
| Manager | Title | Age | Since |
|---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 51 | 2023-03-27 |
| Chief Tech/Sci/R&D Officer | 61 | 2011-09-07 | |
Petra Müller
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2015-04-06 | |
Susan Dexter
BRD | Director/Board Member | 69 | 2015-04-06 |
Lothar Kappich
BRD | Director/Board Member | 69 | 2017-09-13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 12/17/25 | Sell | Company | 750,000 | 0.7706% | ||
| 2/16/24 | Buy | Chief Executive Officer | 1,716,739 | 1.8624% | ||
| 3/2/22 | Sell | Company | 200,442 | 0.2174% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.86% | +1.29% | +12.06% | -24.27% | 22.32B | |
| -1.88% | -5.38% | -16.81% | +5.70% | 195B | |
| -0.64% | -2.89% | -2.33% | +10.13% | 117B | |
| +0.49% | +1.75% | +10.97% | +80.88% | 61.45B | |
| -0.74% | -2.03% | -2.52% | -32.89% | 51.62B | |
| +0.80% | -1.18% | +27.79% | +52.56% | 51.03B | |
| +0.26% | -.--% | +22.56% | -9.82% | 34.27B | |
| -0.71% | +0.95% | - | - | 30.95B | |
| +1.08% | -3.39% | +38.13% | -16.62% | 23.75B | |
| -0.91% | -2.06% | -5.54% | +16.29% | 23.41B | |
| Average | -0.31% | -0.99% | +9.37% | +9.11% | 61.02B | |
| Weighted average by Cap. | -0.71% | -1.80% | +0.41% | +12.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.13B 3.63B 2.93B 2.68B 5.03B 346B 5.07B 34.77B 13.53B 175B 13.63B 13.34B 580B | 3.47B 4.03B 3.25B 2.97B 5.58B 383B 5.62B 38.57B 15.01B 194B 15.12B 14.79B 644B |
| Net income | 379M 440M 356M 325M 610M 41.91B 614M 4.22B 1.64B 21.25B 1.65B 1.62B 70.34B | 481M 559M 451M 412M 774M 53.18B 779M 5.35B 2.08B 26.96B 2.1B 2.05B 89.25B |
| Net Debt | 2.01B 2.33B 1.89B 1.72B 3.23B 222B 3.26B 22.35B 8.7B 113B 8.76B 8.57B 373B | 1.76B 2.05B 1.65B 1.51B 2.83B 195B 2.85B 19.59B 7.62B 98.73B 7.68B 7.51B 327B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-31 | €196.00 | -0.86% | 219,124 |
| 26-08-28 | €197.70 | +0.51% | 56,919 |
| 26-08-27 | €196.70 | +2.45% | 65,436 |
| 26-08-26 | €192.00 | -1.18% | 49,412 |
| 26-08-25 | €194.30 | +1.62% | 65,033 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DIM Stock
Select your edition
All financial news and data tailored to specific country editions
